Product Information

TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB is a generic product labeled by Solco Healthcare US LLC, priced at $0.3483 per EA under NDC 43547044103. Its NADAC has been published 429 times since Aug 29, 2018.

FDA first approved this application on Nov 6, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB

telmisartan and hydrochlorothiazide
$0.3483per EA

Strength

12.5; 40 mg/1; mg/1

NDC

43547044103

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209028

FDA Approved

11/6/2017

TE Code

AB

On Market Since

2/5/2018

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB has been published 429 times since Aug 29, 2018, and over the history we have for it it has declined 80.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3483 per EA
All-time high$2.2627 (Jul 10, 2019)
All-time low$0.2777 (Nov 20, 2024)
52-week high$0.4030
52-week low$0.3483
Median price$0.8548
Average price$1.0161
Largest weekly change+83.5% (Nov 22, 2023)
Weeks tracked429
Tracking sinceAug 29, 2018

Price History

1W

0.0%

1M

-2.4%

3M

-5.3%

6M

-3.9%

1Y

-0.0%

3Y

-14.2%

5Y

-78.8%

All

-80.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB, manufactured by Solco Healthcare US LLC, is $0.3483 per EA (NDC 43547044103), effective Nov 11, 2026.

How has the price of TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB changed over time?

Over the history we have for it, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB has declined 80.4%. It has been tracked across 429 weekly CMS publications since Aug 29, 2018.

What are the highest and lowest recorded NADAC prices for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?

Since Aug 29, 2018, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB has ranged from a low of $0.2777 (Nov 20, 2024) to a high of $2.2627 (Jul 10, 2019), with a median of $0.8548 per EA.

Are there cheaper alternatives to TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB in a comparable dosage form, but none are currently priced below it.

Who manufactures TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?

TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB (NDC 43547044103) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.